TCI Wealth Advisors, Inc. - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is MACK and the CUSIP is 590328209. A total of 74 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q4 2017. The put-call ratio across all filers is 1.37 and the average weighting 0.0%.

Quarter-by-quarter ownership
TCI Wealth Advisors, Inc. ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2017$1,0001000.00%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q4 2017
NameSharesValueWeighting ↓
Western Standard LLC 1,063,267$4,253,0004.83%
22NW, LP 1,241,896$4,968,0002.52%
Newtyn Management, LLC 1,296,436$5,186,0001.26%
Bronte Capital Management Pty Ltd. 531,510$2,052,0000.36%
WITTENBERG INVESTMENT MANAGEMENT, INC. 186,198$620,0000.33%
Nantahala Capital Management 751,943$3,008,0000.09%
Sepio Capital, LP 194,785$779,0000.08%
Yakira Capital Management, Inc. 66,934$268,0000.08%
LVW Advisors, LLC 20,000$80,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 61,700$247,0000.01%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders